E-LIB Suche - Ergebnisse für: Guo Xiling

1

The 6-Month Antibody Durability of Heterologous Convidecia ..:

Jiang, Hudachuan ; Jin, Pengfei ; Guo, Xiling...
Vaccines. 11 (2023) 12 - p. 1815 , 2023

Link: https://doi.org/10.3390/..

2

Immunogenicity consistency and safety with different produc..:

Wu, Yan-Fei ; Wei, Ming-Wei ; Wang, Rui-Jie...
Expert Review of Vaccines. 22 (2023) 1 - p. 662-670 , 2023

Link: https://doi.org/10.1080/..

3

Immunogenicity and safety of heterologous immunisation with..:

Jin, Peng-Fei ; Guo, Xi-Ling ; Gou, Jin-Bo...
The Lancet Regional Health - Western Pacific. 38 (2023) - p. 100829 , 2023

Link: https://doi.org/10.1016/..

4

Environmental Impact Assessment for the Use of an Orally Ae..:

Xia, Xin ; Tan, Zhong-Ming ; Wan, Peng...
The Journal of Infectious Diseases. 228 (2023) 6 - p. 715-722 , 2023

Link: https://doi.org/10.1093/..

5

Safety and immunogenicity of heterologous boost immunizatio..:

Jin, Pengfei ; Guo, Xiling ; Chen, Wei...
PLOS Medicine. 19 (2022) 5 - p. e1003953 , 2022

Link: https://doi.org/10.1371/..

6

Immunogenicity and safety of BNT162b2 mRNA vaccine in Chine..:

Hui, Ai-Min ; Li, Jingxin ; Zhu, Li...
The Lancet Regional Health - Western Pacific. 29 (2022) - p. 100586 , 2022

Link: https://doi.org/10.1016/..

7

Immune Persistence and Safety After SARS-CoV-2 BNT162b1 mRN..:

Li, Jingxin ; Hui, Ai-Min ; Zhang, Xiang...
Advances in Therapy. 39 (2022) 8 - p. 3789-3798 , 2022

Link: https://doi.org/10.1007/..

8

Ultrapotent neutralizing antibodies against SARS-CoV-2 with..:

Zou, Jia ; Li, Li ; Zheng, Peiyi...
Journal of Clinical Investigation. 132 (2022) 4 - p. , 2022

Link: https://doi.org/10.1172/..

9

Effectiveness of Disinfectants Suitable for Inactivating SA..:

Wu, Xiaosong ; Chen, Yin ; Wang, Ling...
Food and Environmental Virology. 14 (2022) 1 - p. 101-104 , 2022

Link: https://doi.org/10.1007/..

10

Antibody persistence and safety after heterologous boosting..:

Jin, Lairun ; Tang, Rong ; Wu, Shipo...
Emerging Microbes & Infections. 12 (2022) 1 - p. , 2022

Link: https://doi.org/10.1080/..

11

Head-to-head comparisons of the neutralizing antibody again..:

Jiang, Hu-Dachuan ; Guo, Xi-ling ; Jin, Peng-Fei...
Emerging Microbes & Infections. 11 (2022) 1 - p. 1751-1753 , 2022

Link: https://doi.org/10.1080/..

12

Heterologous AD5-nCOV plus CoronaVac versus homologous Coro..:

Li, Jingxin ; Hou, Lihua ; Guo, Xiling...
Nature Medicine. 28 (2022) 2 - p. 401-409 , 2022

Link: https://doi.org/10.1038/..

13

An integrative drug repositioning framework discovered a po..:

Ge, Yiyue ; Tian, Tingzhong ; Huang, Suling...
Signal Transduction and Targeted Therapy. 6 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

14

Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA v..:

Li, Jingxin ; Hui, Aimin ; Zhang, Xiang...
Nature Medicine. 27 (2021) 6 - p. 1062-1070 , 2021

Link: https://doi.org/10.1038/..

15

A proof of concept for neutralizing antibody-guided vaccine..:

Zhang, Li ; Cao, Lei ; Gao, Xing-Su...
National Science Review. , 2021

Link: https://doi.org/10.1093/..